Literature DB >> 22059171

Endoscopic treatment of obesity.

Agnieszka Swidnicka-Siergiejko1, Eugeniusz Wróblewski, Dabrowski Andrzej.   

Abstract

BACKGROUND: The increasing incidence of obesity and overweight among children and adolescents will be reflected by the imminent increase in the number of obese patients who require more definitive methods of treatment. There is great interest in new, safe, simple, nonsurgical procedures for weight loss.
OBJECTIVE: To provide an overview of new endoscopic methods for the treatment of obesity.
METHODS: An English-language literature search on endoscopic interventions, endoscopically placed devices and patient safety was performed in the MEDLINE and Cochrane Library databases.
RESULTS: The literature search yielded the following weight loss methods: space-occupying devices (widely used), gastric capacity reduction, modifying gastric motor function and malabsorptive procedures. A commercially available intragastric balloon was the most commonly used device for weight loss. In specific subgroups of patients, it improved quality of life, decreased comorbidities and served as a bridge to surgery. More evidence regarding the potential benefits and safety of other commercially available intragastric balloons is needed to clarify whether they are superior to the most commonly used one. Moreover, early experiences with transoral gastroplasty, the duodenal-jejunal bypass sleeve and an adjustable, totally implantable intragastric prosthesis, indicate that they may be viable options for obesity treatment. Other agents, such as botulinum toxin and a device known as the 'butterfly', are currently at the experimental stage.
CONCLUSION: New endoscopic methods for weight loss may be valuable in the treatment of obesity; however, more clinical experience and technical improvements are necessary before implementing their widespread use.

Entities:  

Mesh:

Year:  2011        PMID: 22059171      PMCID: PMC3222773          DOI: 10.1155/2011/174163

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  68 in total

1.  A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity.

Authors:  D F Kirby; J B Wade; P R Mills; H J Sugerman; J M Kellum; A M Zfass; J V Starkey; R Birkenhauer; R M Hamer
Journal:  Am Surg       Date:  1990-10       Impact factor: 0.688

Review 2.  Obesity and disease of the esophagus and colon.

Authors:  Hashem B El-Serag
Journal:  Gastroenterol Clin North Am       Date:  2005-03       Impact factor: 3.806

3.  Gastroduodenal motility.

Authors:  E M Quigley
Journal:  Curr Opin Gastroenterol       Date:  2000-11       Impact factor: 3.287

4.  Clinical trial of silicone-rubber gastric balloon to treat obesity.

Authors:  A Geliebter; P M Melton; R S McCray; D Gage; S B Heymsfield; M Abiri; S A Hashim
Journal:  Int J Obes       Date:  1991-04

5.  Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon.

Authors:  E M Mathus-Vliegen; G N Tytgat; E A Veldhuyzen-Offermans
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

6.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

7.  Gastric balloon to treat obesity: a double-blind study in nondieting subjects.

Authors:  A Geliebter; P M Melton; D Gage; R S McCray; S A Hashim
Journal:  Am J Clin Nutr       Date:  1990-04       Impact factor: 7.045

8.  Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study.

Authors:  J Devière; G Ojeda Valdes; L Cuevas Herrera; J Closset; O Le Moine; P Eisendrath; C Moreno; S Dugardeyn; M Barea; R de la Torre; S Edmundowicz; S Scott
Journal:  Surg Endosc       Date:  2007-11-01       Impact factor: 4.584

9.  Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats.

Authors:  D Gui; A De Gaetano; P L Spada; A Viggiano; E Cassetta; A Albanese
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

10.  An improved intragastric balloon procedure using a new balloon: preliminary analysis of safety and efficiency.

Authors:  Gustavo L Carvalho; Cesar B Barros; Masaichi Okazaki; Moacir L Novaes; Pedro C Albuquerque; Nair C Almeida; Pedro Paulo C Albuquerque; Chika Wakiyama; Thiago G Vilaça; José Sergio N Silva; Rapahel M Coelho
Journal:  Obes Surg       Date:  2008-06-26       Impact factor: 4.129

View more
  11 in total

Review 1.  The Role of Endoscopic Intra-Gastric Botulinum Toxin-A for Obesity Treatment.

Authors:  Hadya Elshakh; Khalid El-Ejji; Shahrad Taheri
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

2.  Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).

Authors:  Nina Riedel; Katharina Laubner; Anne Lautenbach; Gerhard Schön; Matthias Schlensak; Rainer Stengel; Thomas Eberl; Frank Dederichs; Jens Aberle; Jochen Seufert
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  Efficacy and Safety of Intragastric Balloon Placements in 1600 Case, an Experience from the Middle East.

Authors:  Mohamed Abeid; Tarek Kaddah; Nahla A Zaitoun; Mohd Amer Alsamman
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

Review 4.  ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.

Authors:  Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman
Journal:  Surg Obes Relat Dis       Date:  2018-03-23       Impact factor: 4.734

Review 5.  Impact of obesity treatment on gastroesophageal reflux disease.

Authors:  Abraham Khan; Aram Kim; Cassandra Sanossian; Fritz Francois
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Role of endoscopy in the bariatric surgery of patients.

Authors:  Giovanni D De Palma; Pietro Forestieri
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels.

Authors:  Nina Sauer; Thomas Rösch; Jennifer Pezold; Franziska Reining; Mario Anders; Stefan Groth; Guido Schachschal; Oliver Mann; Jens Aberle
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

8.  Gastric Botulinum Toxin-A Application for Weight Loss Therapy.

Authors:  Ozan Şen; Ahmet Gökhan Türkçapar
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

9.  Gastric electrical stimulation for the treatment of obesity: from entrainment to bezoars-a functional review.

Authors:  Martin P Mintchev
Journal:  ISRN Gastroenterol       Date:  2013-02-07

10.  Various Intragastric Balloons Under Clinical Investigation.

Authors:  Seong Ji Choi; Hyuk Soon Choi
Journal:  Clin Endosc       Date:  2018-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.